Clinical Trials Browser

INDUSTRY × Has results × Goserelin × Clear all

NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

1,083 enrolled 29 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT03056755 2026-01-13

BYLieve

Phase 2 Completed

383 enrolled 16 charts

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT03822468 2025-10-16

AMALEE

Phase 2 Completed

376 enrolled 17 charts

Breast Neoplasms

NCT04478266 2025-09-11

AMEERA-5

Phase 3 Terminated

1,068 enrolled 21 charts

Breast Neoplasms

NCT01673984 2025-05-23

GREAT

Phase 4 Terminated

27 enrolled 13 charts

Prostatic Neoplasms

NCT03839823 2024-10-09

RIGHT Choice

Phase 2 Completed

222 enrolled 17 charts

Breast Neoplasms

NCT04862143 2024-06-20

TELEPIK

Phase 2 Terminated

2 enrolled 10 charts

Advanced Breast Cancer

NCT02278120 2024-03-12

MONALEESA-7

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

NCT02941926 2023-10-24

COMPLEEMENT-1

Phase 3 Completed

3,246 enrolled 11 charts

Breast Neoplasms

NCT03096847 2021-10-11

Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

Phase 3 Completed

502 enrolled 20 charts

Breast Neoplasms, Osteitis Deformans

NCT01790126 2020-03-11

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Phase 2 Completed

90 enrolled 23 charts

Prostatic Neoplasms

NCT01073865 2018-12-12

Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

Phase 3 Completed

222 enrolled 13 charts

Breast Neoplasms

NCT01496131 2018-03-09

Tecemotide (L-BLP25) in Prostate Cancer

Phase 2 Completed

28 enrolled 9 charts

Prostatic Neoplasms

NCT01242748 2015-06-03

A Degarelix Trial in Patients With Prostate Cancer

Phase 3 Terminated

288 enrolled 16 charts

Prostatic Neoplasms

NCT00946920 2014-06-02

A Trial of Degarelix in Patients With Prostate Cancer

Phase 3 Completed

859 enrolled 15 charts

Prostatic Neoplasms

NCT01088529 2014-05-15

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Phase 2 Completed

66 enrolled 12 charts

Prostatic Neoplasms

NCT00884273 2013-11-13

Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

Phase 3 Completed

182 enrolled 26 charts

Prostatic Neoplasms

NCT00831233 2013-11-11

Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Phase 3 Terminated

42 enrolled 22 charts

Prostatic Neoplasms

NCT00833248 2012-10-04

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Phase 3 Completed

246 enrolled 24 charts

Prostatic Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Phase 3 Completed

197 enrolled 23 charts

Breast Neoplasms, Neoplasms

NCT00322348 2011-01-24

Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

Phase 2 Completed

98 enrolled 13 charts

Breast Neoplasms, Neoplasms